AURA实时信号 | 通过Getagraph.com最大化利润

出售 115255 min ago

@ $8.31

发出时间: 15 Feb 2024 @ 04:25

回报率: -5.05%

上一信号: Feb 13 - 22:30

上一信号: 购买

回报率: -2.12 %

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):

Stats
今日成交量	98 873.00
平均成交量	182 508
市值	390.82M
EPS	$0 ( 2024-03-27 )
下一个收益日期	( $-0.510 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.09
ATR14	$0.0210 (0.27%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-02	Kilroy Conor	Buy	144 000	Stock Option (Right to Buy)
2024-04-02	Kilroy Conor	Buy	96 000	Common Stock
2024-04-01	Kilroy Conor	Buy	0
2024-03-15	Plavsic Mark	Sell	0	Common Stock
2024-03-15	Plavsic Mark	Sell	138 000	Stock Option (Right to Buy)

INSIDER POWER
86.85
Last 96 transactions
Buy: 15 662 380 \| Sell: 3 253 163

音量相关性

長: 0.01 (neutral)

短: -0.38 (neutral)

Signal:(37.085) Neutral

Aura Biosciences, Inc. 相关性

10 最正相关
PAIC	0.96
SVAC	0.933
LYEL	0.929
GRNV	0.926
ANGI	0.922
WISA	0.918
EPZM	0.918
CNCE	0.915
GERN	0.91
QLGN	0.909

10 最负相关
NETE	-0.951
MMAC	-0.925
TGLS	-0.92
BNIXU	-0.919
AMRB	-0.918
PMTS	-0.912
LYTS	-0.912
IBEX	-0.907
LRFC	-0.906
SCPL	-0.906

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Aura Biosciences, Inc. 相关性 - 货币/商品

0.42
( neutral )

0.39
( neutral )

0.00
( neutral )

0.39
( neutral )

0.67
( moderate )

-0.70
( moderate negative )

Aura Biosciences, Inc. 财务报表

Annual	2023
营收:	$0
毛利润:	$-1.30M (0.00 %)
EPS:	$-1.930

FY	2023
营收:	$0
毛利润:	$-1.30M (0.00 %)
EPS:	$-1.930

FY	2022
营收:	$0
毛利润:	$-1.18M (0.00 %)
EPS:	$-1.910

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

Aura Biosciences, Inc.

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.

实时更新： Aura Biosciences, Inc. [AURA]

Upcoming Earnings Alert